Genetic determinants of the humoral immune response in MS

Standard

Genetic determinants of the humoral immune response in MS. / Gasperi, Christiane; Andlauer, Till F M; Keating, Ana; Knier, Benjamin; Klein, Ana; Pernpeintner, Verena; Lichtner, Peter; Gold, Ralf; Zipp, Frauke; Then Bergh, Florian; Stangel, Martin; Tumani, Hayrettin; Wildemann, Brigitte; Wiendl, Heinz; Bayas, Antonios; Kümpfel, Tania; Zettl, Uwe K; Linker, Ralf A; Ziemann, Ulf; Knop, Matthias; Warnke, Clemens; Friese, Manuel A; Paul, Friedemann; Tackenberg, Björn; Berthele, Achim; Hemmer, Bernhard.

in: NEUROL-NEUROIMMUNOL, Jahrgang 7, Nr. 5, 09.2020.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Gasperi, C, Andlauer, TFM, Keating, A, Knier, B, Klein, A, Pernpeintner, V, Lichtner, P, Gold, R, Zipp, F, Then Bergh, F, Stangel, M, Tumani, H, Wildemann, B, Wiendl, H, Bayas, A, Kümpfel, T, Zettl, UK, Linker, RA, Ziemann, U, Knop, M, Warnke, C, Friese, MA, Paul, F, Tackenberg, B, Berthele, A & Hemmer, B 2020, 'Genetic determinants of the humoral immune response in MS', NEUROL-NEUROIMMUNOL, Jg. 7, Nr. 5. https://doi.org/10.1212/NXI.0000000000000827

APA

Gasperi, C., Andlauer, T. F. M., Keating, A., Knier, B., Klein, A., Pernpeintner, V., Lichtner, P., Gold, R., Zipp, F., Then Bergh, F., Stangel, M., Tumani, H., Wildemann, B., Wiendl, H., Bayas, A., Kümpfel, T., Zettl, U. K., Linker, R. A., Ziemann, U., ... Hemmer, B. (2020). Genetic determinants of the humoral immune response in MS. NEUROL-NEUROIMMUNOL, 7(5). https://doi.org/10.1212/NXI.0000000000000827

Vancouver

Gasperi C, Andlauer TFM, Keating A, Knier B, Klein A, Pernpeintner V et al. Genetic determinants of the humoral immune response in MS. NEUROL-NEUROIMMUNOL. 2020 Sep;7(5). https://doi.org/10.1212/NXI.0000000000000827

Bibtex

@article{2d778047a018441dae3615fd00203b33,
title = "Genetic determinants of the humoral immune response in MS",
abstract = "OBJECTIVE: In this observational study, we investigated the impact of genetic factors at the immunoglobulin heavy chain constant locus on chromosome 14 and the major histocompatibility complex region on intrathecal immunoglobulin G, A, and M levels as well as on B cells and plasmablasts in the CSF and blood of patients with multiple sclerosis (MS).METHODS: Using regression analyses, we tested genetic variants on chromosome 14 and imputed human leukocyte antigen (HLA) alleles for associations with intrathecal immunoglobulins in 1,279 patients with MS or clinically isolated syndrome and with blood and CSF B cells and plasmablasts in 301 and 348 patients, respectively.RESULTS: The minor alleles of variants on chromosome 14 were associated with higher intrathecal immunoglobulin G levels (β = 0.58 [0.47 to 0.68], lowest adjusted p = 2.32 × 10-23), and lower intrathecal immunoglobulin M (β = -0.56 [-0.67 to -0.46], p = 2.06 × 10-24) and A (β = -0.42 [-0.54 to -0.31], p = 7.48 × 10-11) levels. Alleles from the HLA-B*07:02-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype were associated with higher (lowest p = 2.14 × 10-7) and HLA-B*44:02 with lower (β = -0.35 [-0.54 to -0.17], p = 1.38 × 10-2) immunoglobulin G levels. Of interest, different HLA alleles were associated with lower intrathecal immunoglobulin M (HLA-C*02:02, β = -0.45 [-0.61 to -0.28], p = 1.01 × 10-5) and higher immunoglobulin A levels (HLA-DQA1*01:03-DQB1*06:03-DRB1*13:01 haplotype, β = 0.40 [0.21 to 0.60], p = 4.46 × 10-3). The impact of HLA alleles on intrathecal immunoglobulin G and M levels could mostly be explained by associations with CSF B cells and plasmablasts.CONCLUSION: Although some HLA alleles seem to primarily drive the extent of humoral immune responses in the CNS by increasing CSF B cells and plasmablasts, genetic variants at the immunoglobulin heavy chain constant locus might regulate intrathecal immunoglobulins levels via different mechanisms.",
author = "Christiane Gasperi and Andlauer, {Till F M} and Ana Keating and Benjamin Knier and Ana Klein and Verena Pernpeintner and Peter Lichtner and Ralf Gold and Frauke Zipp and {Then Bergh}, Florian and Martin Stangel and Hayrettin Tumani and Brigitte Wildemann and Heinz Wiendl and Antonios Bayas and Tania K{\"u}mpfel and Zettl, {Uwe K} and Linker, {Ralf A} and Ulf Ziemann and Matthias Knop and Clemens Warnke and Friese, {Manuel A} and Friedemann Paul and Bj{\"o}rn Tackenberg and Achim Berthele and Bernhard Hemmer",
note = "Copyright {\textcopyright} 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.",
year = "2020",
month = sep,
doi = "10.1212/NXI.0000000000000827",
language = "English",
volume = "7",
journal = "NEUROL-NEUROIMMUNOL",
issn = "2332-7812",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Genetic determinants of the humoral immune response in MS

AU - Gasperi, Christiane

AU - Andlauer, Till F M

AU - Keating, Ana

AU - Knier, Benjamin

AU - Klein, Ana

AU - Pernpeintner, Verena

AU - Lichtner, Peter

AU - Gold, Ralf

AU - Zipp, Frauke

AU - Then Bergh, Florian

AU - Stangel, Martin

AU - Tumani, Hayrettin

AU - Wildemann, Brigitte

AU - Wiendl, Heinz

AU - Bayas, Antonios

AU - Kümpfel, Tania

AU - Zettl, Uwe K

AU - Linker, Ralf A

AU - Ziemann, Ulf

AU - Knop, Matthias

AU - Warnke, Clemens

AU - Friese, Manuel A

AU - Paul, Friedemann

AU - Tackenberg, Björn

AU - Berthele, Achim

AU - Hemmer, Bernhard

N1 - Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

PY - 2020/9

Y1 - 2020/9

N2 - OBJECTIVE: In this observational study, we investigated the impact of genetic factors at the immunoglobulin heavy chain constant locus on chromosome 14 and the major histocompatibility complex region on intrathecal immunoglobulin G, A, and M levels as well as on B cells and plasmablasts in the CSF and blood of patients with multiple sclerosis (MS).METHODS: Using regression analyses, we tested genetic variants on chromosome 14 and imputed human leukocyte antigen (HLA) alleles for associations with intrathecal immunoglobulins in 1,279 patients with MS or clinically isolated syndrome and with blood and CSF B cells and plasmablasts in 301 and 348 patients, respectively.RESULTS: The minor alleles of variants on chromosome 14 were associated with higher intrathecal immunoglobulin G levels (β = 0.58 [0.47 to 0.68], lowest adjusted p = 2.32 × 10-23), and lower intrathecal immunoglobulin M (β = -0.56 [-0.67 to -0.46], p = 2.06 × 10-24) and A (β = -0.42 [-0.54 to -0.31], p = 7.48 × 10-11) levels. Alleles from the HLA-B*07:02-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype were associated with higher (lowest p = 2.14 × 10-7) and HLA-B*44:02 with lower (β = -0.35 [-0.54 to -0.17], p = 1.38 × 10-2) immunoglobulin G levels. Of interest, different HLA alleles were associated with lower intrathecal immunoglobulin M (HLA-C*02:02, β = -0.45 [-0.61 to -0.28], p = 1.01 × 10-5) and higher immunoglobulin A levels (HLA-DQA1*01:03-DQB1*06:03-DRB1*13:01 haplotype, β = 0.40 [0.21 to 0.60], p = 4.46 × 10-3). The impact of HLA alleles on intrathecal immunoglobulin G and M levels could mostly be explained by associations with CSF B cells and plasmablasts.CONCLUSION: Although some HLA alleles seem to primarily drive the extent of humoral immune responses in the CNS by increasing CSF B cells and plasmablasts, genetic variants at the immunoglobulin heavy chain constant locus might regulate intrathecal immunoglobulins levels via different mechanisms.

AB - OBJECTIVE: In this observational study, we investigated the impact of genetic factors at the immunoglobulin heavy chain constant locus on chromosome 14 and the major histocompatibility complex region on intrathecal immunoglobulin G, A, and M levels as well as on B cells and plasmablasts in the CSF and blood of patients with multiple sclerosis (MS).METHODS: Using regression analyses, we tested genetic variants on chromosome 14 and imputed human leukocyte antigen (HLA) alleles for associations with intrathecal immunoglobulins in 1,279 patients with MS or clinically isolated syndrome and with blood and CSF B cells and plasmablasts in 301 and 348 patients, respectively.RESULTS: The minor alleles of variants on chromosome 14 were associated with higher intrathecal immunoglobulin G levels (β = 0.58 [0.47 to 0.68], lowest adjusted p = 2.32 × 10-23), and lower intrathecal immunoglobulin M (β = -0.56 [-0.67 to -0.46], p = 2.06 × 10-24) and A (β = -0.42 [-0.54 to -0.31], p = 7.48 × 10-11) levels. Alleles from the HLA-B*07:02-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype were associated with higher (lowest p = 2.14 × 10-7) and HLA-B*44:02 with lower (β = -0.35 [-0.54 to -0.17], p = 1.38 × 10-2) immunoglobulin G levels. Of interest, different HLA alleles were associated with lower intrathecal immunoglobulin M (HLA-C*02:02, β = -0.45 [-0.61 to -0.28], p = 1.01 × 10-5) and higher immunoglobulin A levels (HLA-DQA1*01:03-DQB1*06:03-DRB1*13:01 haplotype, β = 0.40 [0.21 to 0.60], p = 4.46 × 10-3). The impact of HLA alleles on intrathecal immunoglobulin G and M levels could mostly be explained by associations with CSF B cells and plasmablasts.CONCLUSION: Although some HLA alleles seem to primarily drive the extent of humoral immune responses in the CNS by increasing CSF B cells and plasmablasts, genetic variants at the immunoglobulin heavy chain constant locus might regulate intrathecal immunoglobulins levels via different mechanisms.

U2 - 10.1212/NXI.0000000000000827

DO - 10.1212/NXI.0000000000000827

M3 - SCORING: Journal article

C2 - 32675288

VL - 7

JO - NEUROL-NEUROIMMUNOL

JF - NEUROL-NEUROIMMUNOL

SN - 2332-7812

IS - 5

ER -